Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.68 USD | -4.55% | -9.19% | +16.67% |
23/04 | Silo Pharma, Inc. Announces Positive Results for Intranasal PTSD Treatment | CI |
10/04 | Silo Pharma Says It Exercised Option to License Alzheimer's Therapeutic From Columbia University | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.67% | 47.77L | |
-2.35% | 8.91TCr | |
+3.55% | 4.09TCr | |
-14.40% | 3.22TCr | |
+54.31% | 2.51TCr | |
-15.96% | 1.54TCr | |
-15.50% | 1.19TCr | |
-41.29% | 1.19TCr | |
-11.75% | 1.16TCr | |
+6.37% | 903.23Cr |
- Stock Market
- Equities
- SILO Stock
- News Silo Pharma, Inc.
- Silo Pharma, Partner Receive Regulatory Approval to Develop Ketamine Implant for Fibromyalgia Treatment